Chronic Lymphocytic Leukemia Responds to Dermal Chelation
Not Applicable
- Conditions
- Chronic Lymphocytic Leukemia
- Registration Number
- NCT03495492
- Lead Sponsor
- Optimum Health, Natural Healthcare Center
- Brief Summary
The purpose of this clinical trial is to identify 50 participants with Chronic Lymphocytic Leukemia (CLL) and follow their total white blood cell (WBC) counts and absolute lymphocyte counts after performing dermal chelation and administering nutritional therapy
- Detailed Description
The purpose of this clinical trial is to use dermal chelation and hair tissue analysis to identify 50 participants with CLL. The total wbc counts and absolute lymphocyte counts of these participants will be followed after serial dermal chelations and nutritional therapy.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
- Clinical diagnosis of Chronic Lymphocytic Leukemia and has a toxic heavy metal load
- Toxic heavy metal load
Exclusion Criteria
- Pregnant
- Pacemaker implants
- Organ transplant recipients
- Psychotic episodes or epileptic seizures
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Serial Total White Blood Cell Count up to 12 months Total WBC counts taken on a regular interval.
- Secondary Outcome Measures
Name Time Method